These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21679268)

  • 1. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
    Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R;
    J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopathology in methamphetamine-dependent adults 3 years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson RA;
    Drug Alcohol Rev; 2010 Jan; 29(1):12-20. PubMed ID: 20078677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    Am J Addict; 2010; 19(5):385-90. PubMed ID: 20716300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.
    Rawson RA; Gonzales R; Greenwell L; Chalk M
    J Psychoactive Drugs; 2012; 44(4):342-9. PubMed ID: 23210383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of methamphetamine users 2-5 years after outpatient treatment.
    Rawson RA; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
    J Addict Dis; 2002; 21(1):107-19. PubMed ID: 11831496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R
    Eat Disord; 2011; 19(3):259-69. PubMed ID: 21516550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood trauma and METH abuse among men who have sex with men: Implications for intervention.
    Lopez-Patton M; Kumar M; Jones D; Fonseca M; Kumar AM; Nemeroff CB
    J Psychiatr Res; 2016 Jan; 72():1-5. PubMed ID: 26519763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
    Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa.
    Berg MK; Hobkirk AL; Joska JA; Meade CS
    Psychol Trauma; 2017 Jul; 9(4):493-499. PubMed ID: 27710005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.
    Rawson RA; Chudzynski J; Mooney L; Gonzales R; Ang A; Dickerson D; Penate J; Salem BA; Dolezal B; Cooper CB
    Drug Alcohol Depend; 2015 Nov; 156():21-28. PubMed ID: 26371404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers.
    Beyrer C; Razak MH; Jittiwutikarn J; Suriyanon V; Vongchak T; Srirak N; Kawichai S; Tovanabutra S; Rungruengthanakit K; Sawanpanyalert P; Sripaipan T; Celentano DD
    Int J STD AIDS; 2004 Oct; 15(10):697-704. PubMed ID: 15479508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year outcomes of treatment for methamphetamine use.
    Brecht ML; Greenwell L; von Mayrhauser C; Anglin MD
    J Psychoactive Drugs; 2006 Nov; Suppl 3():415-26. PubMed ID: 17357533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy.
    Galloway GP; Polcin D; Kielstein A; Brown M; Mendelson J
    J Psychoactive Drugs; 2007 Nov; Suppl 4():393-400. PubMed ID: 18286727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.